Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States

[1]  Tumaini R. Coker,et al.  Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. , 2023, JAMA.

[2]  Sandy F. Price,et al.  Tuberculosis — United States, 2021 , 2022, MMWR. Morbidity and mortality weekly report.

[3]  Arif Subhan.  Centers for Medicare & Medicaid Services , 2021, Journal of Clinical Engineering.

[4]  Bureau , 2021, La boussole du confiné.

[5]  Richard G. White,et al.  An approach for improving the quality of country-level TB modelling , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  Sandy F. Price,et al.  Tuberculosis — United States, 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[7]  J. Salomon,et al.  Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States , 2020, Epidemiology.

[8]  J. Salomon,et al.  Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States , 2020, American journal of respiratory and critical care medicine.

[9]  Garrett R. Asay,et al.  Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Feehan,et al.  Quantifying population contact patterns in the United States during the COVID-19 pandemic , 2020, Nature Communications.

[11]  Garrett R. Asay,et al.  Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. , 2020, American journal of respiratory and critical care medicine.

[12]  R. Irizarry.  ggplot2 , 2019, Introduction to Data Science.

[13]  Richard G. White,et al.  Improving the quality of modelling evidence used for tuberculosis policy evaluation , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  J. Salomon,et al.  The impact of migration on tuberculosis in the United States. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  Garrett R. Asay,et al.  Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  S. Grosse,et al.  Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations , 2018, Journal of medical economics.

[17]  R. Houben,et al.  Guidance for country-level TB modelling , 2018 .

[18]  T. Lash,et al.  Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015 , 2018, Emerging infectious diseases.

[19]  Stephen J. Wright,et al.  Numerical Optimization , 2018, Fundamental Statistical Inference.

[20]  J. Salomon,et al.  Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model , 2018, American journal of epidemiology.

[21]  Katherine A. Witsman.  Annual Flow Report, U.S. Lawful Permanent Residents: 2017 , 2018 .

[22]  T. Trikalinos,et al.  Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model , 2017, JAMA internal medicine.

[23]  A. Hill,et al.  Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas , 2017, American journal of respiratory and critical care medicine.

[24]  Romain Ragonnet,et al.  Modular programming for tuberculosis control, the “AuTuMN” platform , 2017, BMC Infectious Diseases.

[25]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[26]  Nicolas A. Menzies,et al.  Bayesian Methods for Calibrating Health Policy Models: A Tutorial , 2017, PharmacoEconomics.

[27]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[28]  A. Krist,et al.  Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[29]  A. Hill,et al.  Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012 , 2015, PloS one.

[30]  L. Sharples,et al.  Calibration of Complex Models through Bayesian Evidence Synthesis , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  T. Sterling,et al.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[32]  田村 大輔,et al.  Centers for Disease Control and Prevention(CDC)での生活 , 2013 .

[33]  M. Sculpher,et al.  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  J. Hackman,et al.  Three months of rifapentine and isoniazid for latent tuberculosis infection. , 2011, The New England journal of medicine.

[35]  K. Freedberg,et al.  Priorities for screening and treatment of latent tuberculosis infection in the United States. , 2011, American journal of respiratory and critical care medicine.

[36]  Dirk Eddelbuettel,et al.  Rcpp: Seamless R and C++ Integration , 2011 .

[37]  Alessandro Vespignani,et al.  The GLEaMviz computational tool, a publicly available software to explore realistic epidemic spreading scenarios at the global scale , 2011, BMC infectious diseases.

[38]  C. Hamilton,et al.  Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. , 2009, American journal of respiratory and critical care medicine.

[39]  C. Marra,et al.  Health state utilities in latent and active tuberculosis. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[40]  N. Ríos Burrows,et al.  Causes and costs of hospitalization of tuberculosis patients in the United States. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[41]  D. Mant.  Prevention , 1994, The Lancet.

[42]  H. Chandler.  Database , 1985 .

[43]  F. Eugene Yates,et al.  The national center for health statistics , 1973, Annals of Biomedical Engineering.

[44]  Dmitri A. Jdanov,et al.  Human Mortality Database , 2019, Encyclopedia of Gerontology and Population Aging.

[45]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[46]  Vital Hepatitis Std Aids,et al.  Reported tuberculosis in the United States 2013 , 2014 .

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[48]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[49]  MI Philip LoBue.  Tuberculosis in the United States , 1942, Nature.

[50]  S. E. P T E M B,et al.  U.S. Bureau of Labor Statistics , 1601 .